These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 10955804

  • 21. Which clinical and biological tumor markers proved predictive in the prospective multicenter trial HIT'91--implications for investigating childhood medulloblastoma.
    Grotzer MA, von Hoff K, von Bueren AO, Shalaby T, Hartmann W, Warmuth-Metz M, Emser A, Kortmann RD, Kuehl J, Pietsch T, Rutkowski S.
    Klin Padiatr; 2007; 219(6):312-7. PubMed ID: 18050040
    [Abstract] [Full Text] [Related]

  • 22. Chlamydia trachomatis modulates expression of tumor suppressor gene caveolin-1 and oncogene C-myc in the transformation zone of non-neoplastic cervical tissue.
    Schlott T, Eiffert H, Bohne W, Landgrebe J, Brunner E, Spielbauer B, Knight B.
    Gynecol Oncol; 2005 Sep; 98(3):409-19. PubMed ID: 16005053
    [Abstract] [Full Text] [Related]

  • 23. The effect of changes of N-myc products on the gene expression of heat-shock protein (hsp-70) and nucleolin during differentiation of neuroblastoma cells.
    Murakami T, Ohmori H, Tsuda T, Higashi K.
    Prog Clin Biol Res; 1991 Sep; 366():65-70. PubMed ID: 2068180
    [No Abstract] [Full Text] [Related]

  • 24. [Detection of n-myc gene amplification in neuroblastoma using polymerase chain reaction based methods].
    Melegh Z, Bálint I, Nagy K, Magyarosy E, Galántai I, Szentirmay Z.
    Magy Onkol; 2002 Sep; 46(1):43-8. PubMed ID: 12050681
    [Abstract] [Full Text] [Related]

  • 25. High-resolution mapping of the N-myc amplicon core domain in neuroblastomas.
    Hiemstra JL, Schneider SS, Brodeur GM.
    Prog Clin Biol Res; 1994 Sep; 385():51-7. PubMed ID: 7972237
    [Abstract] [Full Text] [Related]

  • 26. The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2.
    Godfried MB, Veenstra M, v Sluis P, Boon K, v Asperen R, Hermus MC, v Schaik BD, Voûte TP, Schwab M, Versteeg R, Caron HN.
    Oncogene; 2002 Mar 27; 21(13):2097-101. PubMed ID: 11960382
    [Abstract] [Full Text] [Related]

  • 27. Expressions of N-myc and ras oncogene products in neuroblastoma and their correlations with prognosis.
    Nakada K, Fujioka T, Kitagawa H, Takakuwa T, Yamate N.
    Jpn J Clin Oncol; 1993 Jun 27; 23(3):149-55. PubMed ID: 8350488
    [Abstract] [Full Text] [Related]

  • 28. Amplification of N-myc as a prognostic marker for patients with neuroblastoma.
    Schwab M.
    Semin Cancer Biol; 1993 Feb 27; 4(1):13-8. PubMed ID: 8448374
    [Abstract] [Full Text] [Related]

  • 29. Decreased expression of the candidate tumor suppressor gene ING1 is associated with poor prognosis in advanced neuroblastomas.
    Takahashi M, Ozaki T, Todo S, Nakagawara A.
    Oncol Rep; 2004 Oct 27; 12(4):811-6. PubMed ID: 15375504
    [Abstract] [Full Text] [Related]

  • 30. Neuroblastoma: inverse relationship between expression of N-myc and NGF-r.
    Christiansen H, Christiansen NM, Wagner F, Altmannsberger M, Lampert F.
    Oncogene; 1990 Mar 27; 5(3):437-40. PubMed ID: 2156211
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Gene expression of TRK neurotrophin receptors in advanced neuroblastomas in Singapore--a pilot study.
    Fung W, Hasan MY, Loh AH, Chua JH, Yong MH, Knight L, Hwang WS, Chan MY, Seow WT, Jacobsen AS, Chui CH.
    Pediatr Hematol Oncol; 2011 Oct 27; 28(7):571-8. PubMed ID: 21728718
    [Abstract] [Full Text] [Related]

  • 33. Prognostic prediction in neuroblastomas: clinical significance of combined analysis for Ha-ras p21 expression and N-myc gene amplification.
    Tanaka T, Seeger RC, Tanabe M, Hiyama E, Shimoda H, Ida N.
    Cancer Detect Prev; 1994 Oct 27; 18(4):283-9. PubMed ID: 7982238
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Preferential amplification of the paternal allele in neuroblastomas with N-myc amplification.
    Cheng JM, Hiemstra JL, Schneider SS, Kaufman BA, Naumova A, Cheung NK, Cohn SL, Diller L, Sapienza C, Brodeur GM.
    Prog Clin Biol Res; 1994 Oct 27; 385():43-9. PubMed ID: 7972236
    [Abstract] [Full Text] [Related]

  • 37. Detection of N-myc amplification by FISH in immature areas of fixed neuroblastomas: more efficient than Southern blot/PCR.
    Sartelet H, Grossi L, Pasquier D, Combaret V, Bouvier R, Ranchère D, Plantaz D, Munzer M, Philip T, Birembaut P, Zahm JM, Bergeron C, Gaillard D, Pasquier B.
    J Pathol; 2002 Sep 27; 198(1):83-91. PubMed ID: 12210067
    [Abstract] [Full Text] [Related]

  • 38. Biology of neuroblastomas in Japan found by screening.
    Hayashi Y, Hanada R, Yamamoto K.
    Am J Pediatr Hematol Oncol; 1992 Nov 27; 14(4):342-7. PubMed ID: 1456401
    [Abstract] [Full Text] [Related]

  • 39. Hypoxia promotes apoptosis of human neuroblastoma cell lines with enhanced N-myc expression.
    Rössler J, Schwab M, Havers W, Schweigerer L.
    Biochem Biophys Res Commun; 2001 Feb 23; 281(2):272-6. PubMed ID: 11181040
    [Abstract] [Full Text] [Related]

  • 40. Upregulation of macrophage migration inhibitory factor contributes to induced N-Myc expression by the activation of ERK signaling pathway and increased expression of interleukin-8 and VEGF in neuroblastoma.
    Ren Y, Chan HM, Li Z, Lin C, Nicholls J, Chen CF, Lee PY, Lui V, Bacher M, Tam PK.
    Oncogene; 2004 May 20; 23(23):4146-54. PubMed ID: 15064733
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.